Neslihan Meric
Overview
Explore the profile of Neslihan Meric including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meric N, Kar E, Kar F
Mol Biol Rep
. 2024 Sep;
51(1):997.
PMID: 39297923
Background: Thiazole derivatives are gaining prominence in cancer research due to their potent anti-cancer effects and multifaceted biological activities. In leukemia research, these compounds are particularly studied for their ability...
2.
Deciphering avian hematopoietic stem cells by surface marker screening and gene expression profiling
Meric N, Erkan P, Kocabas F
Mol Immunol
. 2024 Sep;
175:20-30.
PMID: 39288684
Background: Avian species have played a pivotal role in developmental hematopoiesis research, leading to numerous critical discoveries. Avian influenza, particularly the H5N1 strain, poses a significant threat to poultry and...
3.
Meric N, Albayrak E, Gulbas Z, Kocabas F
Leuk Lymphoma
. 2023 Oct;
65(2):187-198.
PMID: 37902585
Leukemia stem cells (LSCs) exhibit self-renewal, resistance to standard treatments, and involvement in leukemia relapse. Higher Myeloid Ecotropic Integration Site-1 (MEIS1) expression in leukemic blast samples has been linked to...
4.
Meric N, Kocabas F
Methods Mol Biol
. 2023 Jul;
2736:151-161.
PMID: 37428345
Leukemia stem cells (LSC) are thought to be the basis of leukemia progression since they are highly resistant to conventional chemotherapy. LSC isolation is critical in experimental studies, drug development,...
5.
Meric N, Parmaksiz A, Gulbas Z
Transpl Immunol
. 2023 Apr;
78:101831.
PMID: 37019290
It is important to calculate the CD34+ stem cell (SC) count at the right time in patients with hematological malignancies who will undergo Hematopoietic Stem Cell Transplantation (HSCT). The amount...
6.
Meric N, Parmaksiz A, Gulbas Z
Transfus Clin Biol
. 2022 Aug;
30(1):82-86.
PMID: 35987476
Methods: SARs were examined occurred within 1 hour after initiating HSC product infusions in all HSCT done in Turkey's Anadolu Medical Center Hospital accredited for HSCTs between 2013 and 2015,...
7.
Meric N, Kocabas F
Adv Exp Med Biol
. 2022 Mar;
1387:127-144.
PMID: 35304708
Acute leukemia (AL) is a poor progressive resistant hematological disease, which has different subtypes and immunophenotypic properties according to leukemic blasts. AL is caused by genetic changes and associated with...
8.
Turan R, Albayrak E, Uslu M, Siyah P, Alyazici L, Kalkan B, et al.
Sci Rep
. 2020 May;
10(1):7994.
PMID: 32409701
Meis1, which belongs to TALE-type class of homeobox gene family, appeared as one of the key regulators of hematopoietic stem cell (HSC) self-renewal and a potential therapeutical target. However, small...
9.
Meric N, Guney Esken G, Uslu M, Kocabas F
Adv Exp Med Biol
. 2019 Dec;
1247:65-87.
PMID: 31802445
Platelet and blood transfusions have vital importance to the lives of many patients. Platelet transfusions are a life-saving intervention by reducing risk of bleeding in thrombocytopenic patients. Due to the...
10.
Aksoz M, Albayrak E, Aslan G, Turan R, Alyazici L, Siyah P, et al.
Curr Cancer Drug Targets
. 2018 Sep;
19(6):479-494.
PMID: 30182856
Background: c-Myc plays a major role in the maintenance of glycolytic metabolism and hematopoietic stem cell (HSC) quiescence. Objective: Targeting modulators of HSC quiescence and metabolism could lead to HSC...